Search results
Here's Why You May Invest in Theravance (TBPH) Stock Now
Zacks via Yahoo News· 1 week agoTheravance Biopharma’s TBPH lead pipeline candidate is ampreloxetine, which is being developed for...
Theravance Bio (TBPH) Down 6.1% Since Last Earnings Report: Can It Rebound?
Zacks via Yahoo News· 3 weeks agoIt has been about a month since the last earnings report for Theravance Biopharma (TBPH). Shares...
Theravance (TBPH) Q1 Earnings Top, Revenues Match Estimates
Zacks via Yahoo News· 2 months agoTheravance Biopharma, Inc. TBPH reported first-quarter 2024 adjusted net loss of 9 cents per share,...
Viatris' (VTRS) Q1 Earnings & Sales Lag Estimates, Stock Down
Zacks via Yahoo News· 2 months agoViatris Inc. VTRS delivered adjusted earnings of 67 cents per share in the first quarter of 2024,...
Viatris (VTRS) Q1 Earnings: How Key Metrics Compare to Wall Street Estimates
Zacks via Yahoo News· 2 months agoWhile the top- and bottom-line numbers for Viatris (VTRS) give a sense of how the business performed...
Viatris (VTRS) Q1 Earnings and Revenues Miss Estimates
Zacks via Yahoo News· 2 months agoViatris (VTRS) delivered earnings and revenue surprises of -1.47% and 2.12%, respectively, for the...
Why Earnings Season Could Be Great for Viatris (VTRS)
Zacks via Yahoo News· 2 months agoInvestors are always looking for stocks that are poised to beat at earnings season and Viatris Inc....
Watch These 5 Drug Stocks for Q1 Earnings: Beat or Miss?
Zacks via Yahoo News· 2 months agoThe earnings season for the drug/biotech sector is now in its final lap, with two S&P 500 companies,...
Viatris (VTRS) to Report Q1 Earnings: Is a Beat in Store?
Zacks via Yahoo News· 2 months agoViatris VTRS, a global healthcare company, is scheduled to report first-quarter results on May 9,...
Viatris (VTRS) Expected to Beat Earnings Estimates: Should You Buy?
Zacks via Yahoo News· 2 months agoViatris (VTRS) possesses the right combination of the two key ingredients for a likely earnings beat...